Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide

by Gabriele D. Maurer, Sonja Heller, Christina Wanka, Johannes Rieger, Joachim P. Steinbach
Published 2019-03-01

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

by Michael C Burger, Pia S Zeiner, Kolja Jahnke, Marlies Wagner, Michel Mittelbronn, Joachim P Steinbach
Published 2016-01-01

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

by Michael C. Burger, Michael C. Burger, Michael C. Burger, Michael C. Burger, Congcong Zhang, Congcong Zhang, Congcong Zhang, Patrick N. Harter, Patrick N. Harter, Patrick N. Harter, Patrick N. Harter, Annette Romanski, Florian Strassheimer, Florian Strassheimer, Christian Senft, Christian Senft, Christian Senft, Torsten Tonn, Torsten Tonn, Torsten Tonn, Torsten Tonn, Joachim P. Steinbach, Joachim P. Steinbach, Joachim P. Steinbach, Joachim P. Steinbach, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels
Published 2019-11-01

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern

by Michael C. Burger, Iris C. Mildenberger, Marlies Wagner, Michel Mittelbronn, Joachim P. Steinbach, Oliver Bähr
Published 2017-03-01

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition

by Hans Urban, Laurent M. Willems, Michael W. Ronellenfitsch, Felix Rosenow, Joachim P. Steinbach, Adam Strzelczyk
Published 2020-01-01

Single-shot bevacizumab for cerebral radiation injury

by Martin Voss, Katharina J. Wenger, Emmanouil Fokas, Marie-Thérèse Forster, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2021-02-01

Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment

by Dennis Heinzen, Iris Divé, Nadja I. Lorenz, Anna-Luisa Luger, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2019-09-01

Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet

by Martin Voss, Nadja I. Lorenz, Anna-Luisa Luger, Joachim P. Steinbach, Johannes Rieger, Michael W. Ronellenfitsch
Published 2018-08-01

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.

by Eike Steidl, Ulrich Pilatus, Elke Hattingen, Joachim P Steinbach, Friedhelm Zanella, Michael W Ronellenfitsch, Oliver Bähr
Published 2016-01-01

Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases

by Michael C. Burger, Marlies Wagner, Kea Franz, Patrick N. Harter, Oliver Bähr, Joachim P. Steinbach, Christian Senft
Published 2018-08-01

Bevacizumab for Patients with Recurrent Multifocal Glioblastomas

by Michael C. Burger, Stella Breuer, Hans C. Cieplik, Patrick N. Harter, Kea Franz, Oliver Bähr, Joachim P. Steinbach
Published 2017-11-01

Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation

by Sonja Heller, Gabriele D. Maurer, Christina Wanka, Ute Hofmann, Anna-Luisa Luger, Ines Bruns, Joachim P. Steinbach, Johannes Rieger
Published 2018-07-01

Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide

by Nadja I. Lorenz, Alina C. M. Sittig, Hans Urban, Anna-Luisa Luger, Anna L. Engel, Christian Münch, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2021-07-01

A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury

by Martin A. Schaller-Paule, Peter Baumgarten, Volker Seifert, Marlies Wagner, Eike Steidl, Elke Hattingen, Felix Wicke, Joachim P. Steinbach, Christian Foerch, Juergen Konczalla
Published 2021-01-01

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab

by Martin Voss, AbdulAziz Batarfi, Eike Steidl, Marlies Wagner, Marie-Thérèse Forster, Joachim P. Steinbach, Claus M. Rödel, Jörg Bojunga, Michael W. Ronellenfitsch
Published 2019-10-01

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

by Michael W. Ronellenfitsch, Pia S. Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P. Steinbach, Manfred Westphal, Patrick N. Harter
Published 2018-08-01

Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve <i>IDH</i> Wild-Type Glioma

by Gabriele D. Maurer, Julia Tichy, Patrick N. Harter, Ulrike Nöth, Lutz Weise, Johanna Quick-Weller, Ralf Deichmann, Joachim P. Steinbach, Oliver Bähr, Elke Hattingen
Published 2021-08-01

Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer

by Hans Urban, Gabriele D. Maurer, Anna-Luisa Luger, Nadja I. Lorenz, Benedikt Sauer, Christopher Stroh, Jörg Trojan, Michel Mittelbronn, Joachim P. Steinbach, Patrick N. Harter, Michael W. Ronellenfitsch
Published 2020-10-01

Non-Invasive Measurement of Drug and 2-HG Signals Using ¹⁹F and ¹H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032

by Katharina J. Wenger, Christian Richter, Michael C. Burger, Hans Urban, Stefan Kaulfuss, Patrick N. Harter, Sridhar Sreeramulu, Harald Schwalbe, Joachim P. Steinbach, Elke Hattingen, Oliver Bähr, Ulrich Pilatus
Published 2020-10-01

Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.

by Sebastian Fischer, Michael W Ronellenfitsch, Anna-Luisa Thiepold, Patrick N Harter, Sebastian Reichert, Donat Kögel, Reinhard Paschke, Michel Mittelbronn, Michael Weller, Joachim P Steinbach, Simone Fulda, Oliver Bähr
Published 2014-01-01